Corrigendum to “Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter experience” [Leukemia Res. 114 (March 2022) 106803]

Bibliographic Details
Title: Corrigendum to “Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter experience” [Leukemia Res. 114 (March 2022) 106803]
Authors: De Bellis, Eleonora, Imbergamo, Silvia, Candoni, Anna, Liço, Albana, Tanasi, Ilaria, Mauro, Endri, Mosna, Federico, Leoncin, Matteo, Stulle, Manuela, Griguolo, Davide, Pravato, Stefano, Trentin, Livio, Lazzarotto, Davide, Di Bona, Eros, Sancetta, Rosaria, Lucchini, Elisa, Poiani, Monica, Palmieri, Clara, Zaja, Francesco
Source: In Leukemia Research April 2022 115
Database: ScienceDirect
More Details
ISSN:01452126
DOI:10.1016/j.leukres.2022.106811
Published in:Leukemia Research
Language:English